Literature DB >> 9255791

Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A.

K Ohno1, K Sawai, Y Iijima, B Levin, D Meruelo.   

Abstract

Sindbis virus can infect a broad range of insect and vertebrate cell types due to the widespread distribution of the cellular receptor for the virus. The development of Sindbis virus vectors that target specific cell types could have important implications for the design of gene therapy strategies. To achieve this goal we have designed and constructed Sindbis virus particles displaying the IgG-binding domain of protein A. The protein A-envelope chimeric Sindbis virus vector has minimal infectivities against baby hamster kidney and human cell lines. When used in conjunction with monoclonal antibodies that react with cell-surface antigens, however, the protein A-envelope chimeric virus was able to infect human cell lines with high efficiency. Infection rates were 90% or higher for human lymphoblastoid cells. A variety of cells could be targeted by changing the monoclonal antibody without generating a new recombinant virus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9255791     DOI: 10.1038/nbt0897-763

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  40 in total

1.  Coupling of antibodies via protein Z on modified polyoma virus-like particles.

Authors:  S Gleiter; H Lilie
Journal:  Protein Sci       Date:  2001-02       Impact factor: 6.725

Review 2.  Nucleic acid vaccines: tasks and tactics.

Authors:  B S McKenzie; A J Corbett; J L Brady; C M Dyer; R A Strugnell; S J Kent; D R Kramer; J S Boyle; A M Lew
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

3.  Antibody-directed targeting of retroviral vectors via cell surface antigens.

Authors:  K Morizono; G Bristol; Y M Xie ; S K Kung; I S Chen
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

4.  Conjugation of an antibody Fv fragment to a virus coat protein: cell-specific targeting of recombinant polyoma-virus-like particles.

Authors:  K Stubenrauch; S Gleiter; U Brinkmann; R Rudolph; H Lilie
Journal:  Biochem J       Date:  2001-06-15       Impact factor: 3.857

5.  Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection.

Authors:  Graham Simmons; Andrew J Rennekamp; Ning Chai; Luk H Vandenberghe; James L Riley; Paul Bates
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

6.  Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridge.

Authors:  Nikolay Korokhov; Galina Mikheeva; Alexander Krendelshchikov; Natalya Belousova; Vera Simonenko; Valentina Krendelshchikova; Alexander Pereboev; Alexander Kotov; Olga Kotova; Pierre L Triozzi; Wayne A Aldrich; Joanne T Douglas; Kin-Ming Lo; Papia T Banerjee; Stephen D Gillies; David T Curiel; Victor Krasnykh
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

7.  Engineered lactic acid bacterium Lactococcus lactis capable of binding antibodies and tumor necrosis factor alpha.

Authors:  Matjaz Ravnikar; Borut Strukelj; Natasa Obermajer; Mojca Lunder; Ales Berlec
Journal:  Appl Environ Microbiol       Date:  2010-08-27       Impact factor: 4.792

8.  Functional characterization of the Sindbis virus E2 glycoprotein by transposon linker-insertion mutagenesis.

Authors:  Chanakha K Navaratnarajah; Richard J Kuhn
Journal:  Virology       Date:  2007-02-15       Impact factor: 3.616

9.  Targeted transduction via CD4 by a lentiviral vector uses a clathrin-mediated entry pathway.

Authors:  Min Liang; Kouki Morizono; Nonia Pariente; Masakazu Kamata; Benhur Lee; Irvin S Y Chen
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

10.  Antibody-mediated targeted gene transfer of helper virus-free HSV-1 vectors to rat neocortical neurons that contain either NMDA receptor 2B or 2A subunits.

Authors:  Haiyan Cao; Guo-rong Zhang; Alfred I Geller
Journal:  Brain Res       Date:  2011-08-11       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.